These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10348719)

  • 1. Alzheimer's disease: the tacrine legacy.
    Kelly JS
    Trends Pharmacol Sci; 1999 Apr; 20(4):127-9. PubMed ID: 10348719
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease: new pharmacological perspectives.
    Palacios JM
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():67-8. PubMed ID: 8899698
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacoepidemiology of tacrine in Alzheimer's disease.
    Begaud B; Haramburu F; Miremont G
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():77-8. PubMed ID: 8899701
    [No Abstract]   [Full Text] [Related]  

  • 4. Tacrine in Alzheimer's disease.
    Levy R
    Lancet; 1989 Aug; 2(8658):329. PubMed ID: 2569126
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction of motoric agitation and restlessness by AF102B and tacrine in the macaque.
    Fitten LJ; Ortiz F; Siembieda DW; O'Neill J; Halgren E; Fisher A
    J Neuropsychiatry Clin Neurosci; 1999; 11(1):79-85. PubMed ID: 9990560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrine, and Alzheimer's treatments.
    Summers WK
    J Alzheimers Dis; 2006; 9(3 Suppl):439-45. PubMed ID: 16914883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease: the role of tacrine therapy.
    Jogerst G
    Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholinergic delirium and neurotoxicity associated with tacrine for Alzheimer's dementia.
    Trzepacz PT; Ho V; Mallavarapu H
    Psychosomatics; 1996; 37(3):299-301. PubMed ID: 8849507
    [No Abstract]   [Full Text] [Related]  

  • 9. Alzheimer's disease.
    Hier DB
    Surg Neurol; 1997 Jan; 47(1):84-5. PubMed ID: 8986173
    [No Abstract]   [Full Text] [Related]  

  • 10. Alzheimer's disease: a treatment in sight?
    Lovestone S; Howard R
    J Neurol Neurosurg Psychiatry; 1995 Dec; 59(6):566-7. PubMed ID: 7500092
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tetrahydroaminoacridine: a promising 'therapy' for Alzheimer's disease?].
    Drukarch B; Stoof JC
    Ned Tijdschr Geneeskd; 1988 Oct; 132(40):1833-5. PubMed ID: 3185771
    [No Abstract]   [Full Text] [Related]  

  • 12. Treating Alzheimer's disease with cholinergic drugs, Part I.
    Terpstra T; Terpstra T
    Nurse Pract; 1998 Nov; 23(11):90, 92, 97 passim. PubMed ID: 9834506
    [No Abstract]   [Full Text] [Related]  

  • 13. Design of new drugs for the treatment of Alzheimer's disease based on tacrine structure.
    de Aquino RA; Modolo LV; Alves RB; de Fatima A
    Curr Drug Targets; 2013 Mar; 14(3):378-97. PubMed ID: 23176115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of patients with Alzheimer's disease under treatment with tacrine].
    García-López MT; Guardado-Santervás P
    Rev Neurol; 2001 Feb 16-28; 32(4):394-7. PubMed ID: 11398762
    [No Abstract]   [Full Text] [Related]  

  • 15. A risk-benefit assessment of tacrine in the treatment of Alzheimer's disease.
    Samuels SC; Davis KL
    Drug Saf; 1997 Jan; 16(1):66-77. PubMed ID: 9010644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic results: tacrine].
    Ventura M; Sternon J
    Rev Med Brux; 1997 Dec; 18(6):394-7. PubMed ID: 9481161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy.
    Alhainen K; Riekkinen PJ
    Acta Neurol Scand Suppl; 1993; 149():16-21. PubMed ID: 7907454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A balanced debate on tacrine is necessary].
    Marcusson J
    Lakartidningen; 1996 Mar; 93(13):1200, 1203. PubMed ID: 8656832
    [No Abstract]   [Full Text] [Related]  

  • 19. Maximizing function in Alzheimer's disease: what role for tacrine?
    Smucker WD
    Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease.
    Patocka J; Jun D; Kuca K
    Curr Drug Metab; 2008 May; 9(4):332-5. PubMed ID: 18473751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.